Cathepsin cysteine protease inhibitors
US8318748B2 · kind B2 · utility
2Cited by
3References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 25, 2011 |
| Grant date | Nov 27, 2012 |
| Priority date | — |
| Expiry date | May 25, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.